3 employees
Bioprognos is a spin-off of the Hospital Clínic of Barcelona that aims to improve clinical outcomes and quality of life for cancer.
2016
$416K
from 1 investors over 1 rounds
Bioprognos raised $416K on August 2, 2016
Investors: Capital Cell